Nelson P G
Br Med J. 1970 Sep 26;3(5725):735-7. doi: 10.1136/bmj.3.5725.735.
The effect of intravenous heparin in a therapeutic dosage on cardiac arrhythmias in patients with indubitable acute myocardial infarction was investigated. The value of serum free-fatty-acids (F.F.A.s) and plasma catecholamines in the prediction of patients vulnerable to serious arrhythmias was also studied.Heparin produced a significant rise in F.F.A., maximal within 10 minutes of injection, but did not increase the incidence of cardiac arrhythmias.No relationship was found between the incidence of arrhythmias and the initial levels of F.F.A. or adrenaline. No correlation was obtained between F.F.A. and plasma catecholamine levels. Heparin did not have a consistent effect on plasma catecholamines. Initial control plasma noradrenaline concentrations, however, were found to be significantly correlated with the incidence of subsequent arrhythmias. It is suggested that the level of plasma noradrenaline may be a valuable predictive guide to those patients likely to develop significant arrhythmias after acute myocardial infarction.
研究了治疗剂量的静脉注射肝素对确诊为急性心肌梗死患者心律失常的影响。还研究了血清游离脂肪酸(F.F.A.s)和血浆儿茶酚胺在预测易发生严重心律失常患者方面的价值。肝素使F.F.A.显著升高,注射后10分钟内达到最大值,但并未增加心律失常的发生率。未发现心律失常的发生率与F.F.A.或肾上腺素的初始水平之间存在关联。F.F.A.与血浆儿茶酚胺水平之间未获得相关性。肝素对血浆儿茶酚胺没有一致的影响。然而,发现初始对照血浆去甲肾上腺素浓度与随后心律失常的发生率显著相关。有人提出,血浆去甲肾上腺素水平可能是急性心肌梗死后可能发生严重心律失常患者的有价值的预测指标。